NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
5.03
-0.10 (-1.95%)
At close: Aug 29, 2025, 4:00 PM
5.30
+0.27 (5.37%)
After-hours: Aug 29, 2025, 5:55 PM EDT
NextCure Market Cap
NextCure has a market cap or net worth of $13.46 million as of August 29, 2025. Its market cap has decreased by -68.76% in one year.
Market Cap
13.46M
Enterprise Value
-16.26M
1-Year Change
-68.76%
Ranking
Category
Stock Price
$5.03
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $13.46M, a decrease of -96.92%. That is a compound annual growth rate of -42.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 13.46M | -37.66% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | 300.33M | -80.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.11B |
| Johnson & Johnson | 422.54B |
| AbbVie | 367.30B |
| UnitedHealth Group | 273.78B |
| Novo Nordisk | 249.15B |
| AstraZeneca | 247.41B |
| Novartis AG | 245.07B |
| Abbott Laboratories | 228.64B |